Sabra Health Care REIT Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $21.93. The average 1-year stock price forecast is 8.78% higher than the current stock price, while the lowest is $19 (-5.75%) and the highest is $25 (+24.01%).

Price Target: $21.93 (+8.78%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$19	$21.93	$22	$25
Change	-5.75%	+8.78%	+9.13%	+24.01%

Analyst Ratings

The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	5	5	5	5	4	5
Buy	1	1	1	1	1	1
Hold	8	8	7	7	9	9
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	14	14	13	13	15	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Wells Fargo No rating	Wells Fargo	Buy Maintains $18 → $27	Buy	Maintains	$18 → $27	+33.93%	Jul 15, 2026
Michael Goldsmith UBS	UBS	Hold Reiterates $22 → $21	Hold	Reiterates	$22 → $21	+4.17%	Jul 8, 2026
Michael Lewis Truist Financial	Truist Financial	Buy Upgrades $22	Buy	Upgrades	$22	+9.13%	Jul 8, 2026
Richard Hightower Barclays	Barclays	Hold Initiates $21	Hold	Initiates	$21	+4.17%	Jul 7, 2026
Seth Bergey Citi	Citi	Hold Downgrades $24 → $19	Hold	Downgrades	$24 → $19	-5.75%	Jun 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

889.50M

from 775.76M

14.66%

from 775.76M

Revenue Next Year

983.11M

from 889.50M

10.52%

from 889.50M

EPS This Year

0.67

from -

EPS Next Year

0.74

from 0.67

10.94%

from 0.67

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	388.24M	531.95M	644.62M	702.64M	775.76M	889.50M
Revenue Growth	-35.38%	37.02%	21.18%	9.00%	10.41%	14.66%
Net Income	-113.26M	-77.61M	13.76M	126.71M	155.61M	176.82M
EPS	-	-	-	-	-	0.67
Dividend / Share	1.20	1.20	1.20	1.20	1.20	1.21
Dividend Growth	-	-	-	-	-	0.52%
FFO	253.22M	295.88M	296.50M	321.61M	360.87M	401.26M
FFO / Share	1.15	1.28	1.27	1.36	1.48	1.54
P/FFO	8.22	7.41	9.43	11.56	12.43	13.06
No. Analysts	-	-	-	-	-	5

EPS based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	944.0M
Avg	889.5M
Low	800.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	21.7%
Avg	14.7%
Low	3.2%

EPS Forecast

EPS	2026	2027	2028
High	0.67
Avg	0.67
Low	0.67

EPS Growth

EPS Growth	2026	2027	2028
High	11.1%
Avg	11.1%
Low	11.1%